世界の消化管間質腫瘍市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gastrointestinal Stromal Tumor Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2500 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、消化管間質腫瘍のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（胃、小腸、その他）、用途別市場規模（病院、クリニック、専門がん治療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・消化管間質腫瘍の市場動向 ・企業の競争状況、市場シェア ・消化管間質腫瘍の種類別市場規模（胃、小腸、その他） ・消化管間質腫瘍の用途別市場規模（病院、クリニック、専門がん治療センター、その他） ・消化管間質腫瘍の北米市場規模2016-2027（アメリカ、カナダ） ・消化管間質腫瘍のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・消化管間質腫瘍のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・消化管間質腫瘍の中南米市場規模2016-2027（メキシコ、ブラジル） ・消化管間質腫瘍の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、​​Sun Pharmaceutical、Pfizer、Bayer Aktiengesellschaft、NATCO Pharma） ・結論

Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract.
Treatment of gastrointestinal stromal tumor is multidisciplinary, entailing the involvement of medical oncologists, surgeons, radiologist, as well as pathologists. Until now, the role of radiotherapy in treatment of gastrointestinal stromal tumor remains decisively unestablished. For being inoperable, patients suffering from this malignant tumor opt for symptomatic treatments such as conventional chemotherapy.

Market Analysis and Insights: Global Gastrointestinal Stromal Tumor Market
The global Gastrointestinal Stromal Tumor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gastrointestinal Stromal Tumor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gastrointestinal Stromal Tumor market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gastrointestinal Stromal Tumor market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gastrointestinal Stromal Tumor market.

Global Gastrointestinal Stromal Tumor Scope and Market Size
Gastrointestinal Stromal Tumor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Stromal Tumor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Stomach
Small Intestine
Others

Segment by Application
Hospitals
Clinics
Specialized Cancer Treatment Centers
Other End Users

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
​​Sun Pharmaceutical
Pfizer
Bayer Aktiengesellschaft
NATCO Pharma

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Stomach
1.2.3 Small Intestine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Gastrointestinal Stromal Tumor Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Specialized Cancer Treatment Centers
1.3.5 Other End Users
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gastrointestinal Stromal Tumor Market Perspective (2016-2027)
2.2 Gastrointestinal Stromal Tumor Growth Trends by Regions
2.2.1 Gastrointestinal Stromal Tumor Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gastrointestinal Stromal Tumor Historic Market Share by Regions (2016-2021)
2.2.3 Gastrointestinal Stromal Tumor Forecasted Market Size by Regions (2022-2027)
2.3 Gastrointestinal Stromal Tumor Industry Dynamic
2.3.1 Gastrointestinal Stromal Tumor Market Trends
2.3.2 Gastrointestinal Stromal Tumor Market Drivers
2.3.3 Gastrointestinal Stromal Tumor Market Challenges
2.3.4 Gastrointestinal Stromal Tumor Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Stromal Tumor Players by Revenue
3.1.1 Global Top Gastrointestinal Stromal Tumor Players by Revenue (2016-2021)
3.1.2 Global Gastrointestinal Stromal Tumor Revenue Market Share by Players (2016-2021)
3.2 Global Gastrointestinal Stromal Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Stromal Tumor Revenue
3.4 Global Gastrointestinal Stromal Tumor Market Concentration Ratio
3.4.1 Global Gastrointestinal Stromal Tumor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor Revenue in 2020
3.5 Gastrointestinal Stromal Tumor Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Stromal Tumor Product Solution and Service
3.7 Date of Enter into Gastrointestinal Stromal Tumor Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gastrointestinal Stromal Tumor Breakdown Data by Type
4.1 Global Gastrointestinal Stromal Tumor Historic Market Size by Type (2016-2021)
4.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Type (2022-2027)

5 Gastrointestinal Stromal Tumor Breakdown Data by Application
5.1 Global Gastrointestinal Stromal Tumor Historic Market Size by Application (2016-2021)
5.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gastrointestinal Stromal Tumor Market Size (2016-2027)
6.2 North America Gastrointestinal Stromal Tumor Market Size by Type
6.2.1 North America Gastrointestinal Stromal Tumor Market Size by Type (2016-2021)
6.2.2 North America Gastrointestinal Stromal Tumor Market Size by Type (2022-2027)
6.2.3 North America Gastrointestinal Stromal Tumor Market Size by Type (2016-2027)
6.3 North America Gastrointestinal Stromal Tumor Market Size by Application
6.3.1 North America Gastrointestinal Stromal Tumor Market Size by Application (2016-2021)
6.3.2 North America Gastrointestinal Stromal Tumor Market Size by Application (2022-2027)
6.3.3 North America Gastrointestinal Stromal Tumor Market Size by Application (2016-2027)
6.4 North America Gastrointestinal Stromal Tumor Market Size by Country
6.4.1 North America Gastrointestinal Stromal Tumor Market Size by Country (2016-2021)
6.4.2 North America Gastrointestinal Stromal Tumor Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Gastrointestinal Stromal Tumor Market Size (2016-2027)
7.2 Europe Gastrointestinal Stromal Tumor Market Size by Type
7.2.1 Europe Gastrointestinal Stromal Tumor Market Size by Type (2016-2021)
7.2.2 Europe Gastrointestinal Stromal Tumor Market Size by Type (2022-2027)
7.2.3 Europe Gastrointestinal Stromal Tumor Market Size by Type (2016-2027)
7.3 Europe Gastrointestinal Stromal Tumor Market Size by Application
7.3.1 Europe Gastrointestinal Stromal Tumor Market Size by Application (2016-2021)
7.3.2 Europe Gastrointestinal Stromal Tumor Market Size by Application (2022-2027)
7.3.3 Europe Gastrointestinal Stromal Tumor Market Size by Application (2016-2027)
7.4 Europe Gastrointestinal Stromal Tumor Market Size by Country
7.4.1 Europe Gastrointestinal Stromal Tumor Market Size by Country (2016-2021)
7.4.2 Europe Gastrointestinal Stromal Tumor Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Stromal Tumor Market Size (2016-2027)
8.2 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Type
8.2.1 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Type (2016-2027)
8.3 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Application
8.3.1 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Application (2016-2027)
8.4 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region
8.4.1 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gastrointestinal Stromal Tumor Market Size (2016-2027)
9.2 Latin America Gastrointestinal Stromal Tumor Market Size by Type
9.2.1 Latin America Gastrointestinal Stromal Tumor Market Size by Type (2016-2021)
9.2.2 Latin America Gastrointestinal Stromal Tumor Market Size by Type (2022-2027)
9.2.3 Latin America Gastrointestinal Stromal Tumor Market Size by Type (2016-2027)
9.3 Latin America Gastrointestinal Stromal Tumor Market Size by Application
9.3.1 Latin America Gastrointestinal Stromal Tumor Market Size by Application (2016-2021)
9.3.2 Latin America Gastrointestinal Stromal Tumor Market Size by Application (2022-2027)
9.3.3 Latin America Gastrointestinal Stromal Tumor Market Size by Application (2016-2027)
9.4 Latin America Gastrointestinal Stromal Tumor Market Size by Country
9.4.1 Latin America Gastrointestinal Stromal Tumor Market Size by Country (2016-2021)
9.4.2 Latin America Gastrointestinal Stromal Tumor Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Stromal Tumor Market Size (2016-2027)
10.2 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Type
10.2.1 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Type (2016-2027)
10.3 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Application
10.3.1 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Application (2016-2027)
10.4 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country
10.4.1 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Gastrointestinal Stromal Tumor Introduction
11.1.4 Novartis Revenue in Gastrointestinal Stromal Tumor Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 ​​Sun Pharmaceutical
11.2.1 ​​Sun Pharmaceutical Company Details
11.2.2 ​​Sun Pharmaceutical Business Overview
11.2.3 ​​Sun Pharmaceutical Gastrointestinal Stromal Tumor Introduction
11.2.4 ​​Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Business (2016-2021)
11.2.5 ​​Sun Pharmaceutical Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Gastrointestinal Stromal Tumor Introduction
11.3.4 Pfizer Revenue in Gastrointestinal Stromal Tumor Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Bayer Aktiengesellschaft
11.4.1 Bayer Aktiengesellschaft Company Details
11.4.2 Bayer Aktiengesellschaft Business Overview
11.4.3 Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Introduction
11.4.4 Bayer Aktiengesellschaft Revenue in Gastrointestinal Stromal Tumor Business (2016-2021)
11.4.5 Bayer Aktiengesellschaft Recent Development
11.5 NATCO Pharma
11.5.1 NATCO Pharma Company Details
11.5.2 NATCO Pharma Business Overview
11.5.3 NATCO Pharma Gastrointestinal Stromal Tumor Introduction
11.5.4 NATCO Pharma Revenue in Gastrointestinal Stromal Tumor Business (2016-2021)
11.5.5 NATCO Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Stomach
Table 3. Key Players of Small Intestine
Table 4. Key Players of Others
Table 5. Global Gastrointestinal Stromal Tumor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gastrointestinal Stromal Tumor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Gastrointestinal Stromal Tumor Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Gastrointestinal Stromal Tumor Market Share by Regions (2016-2021)
Table 9. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Gastrointestinal Stromal Tumor Market Share by Regions (2022-2027)
Table 11. Gastrointestinal Stromal Tumor Market Trends
Table 12. Gastrointestinal Stromal Tumor Market Drivers
Table 13. Gastrointestinal Stromal Tumor Market Challenges
Table 14. Gastrointestinal Stromal Tumor Market Restraints
Table 15. Global Gastrointestinal Stromal Tumor Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Gastrointestinal Stromal Tumor Market Share by Players (2016-2021)
Table 17. Global Top Gastrointestinal Stromal Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Stromal Tumor as of 2020)
Table 18. Ranking of Global Top Gastrointestinal Stromal Tumor Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Gastrointestinal Stromal Tumor Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gastrointestinal Stromal Tumor Product Solution and Service
Table 22. Date of Enter into Gastrointestinal Stromal Tumor Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gastrointestinal Stromal Tumor Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Gastrointestinal Stromal Tumor Revenue Market Share by Type (2016-2021)
Table 26. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Gastrointestinal Stromal Tumor Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Gastrointestinal Stromal Tumor Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Gastrointestinal Stromal Tumor Revenue Market Share by Application (2016-2021)
Table 30. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Gastrointestinal Stromal Tumor Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Gastrointestinal Stromal Tumor Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Gastrointestinal Stromal Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Gastrointestinal Stromal Tumor Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Gastrointestinal Stromal Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Gastrointestinal Stromal Tumor Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Gastrointestinal Stromal Tumor Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Gastrointestinal Stromal Tumor Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Gastrointestinal Stromal Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Gastrointestinal Stromal Tumor Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Gastrointestinal Stromal Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Gastrointestinal Stromal Tumor Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Gastrointestinal Stromal Tumor Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Gastrointestinal Stromal Tumor Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Gastrointestinal Stromal Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Gastrointestinal Stromal Tumor Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Gastrointestinal Stromal Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Gastrointestinal Stromal Tumor Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Gastrointestinal Stromal Tumor Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2022-2027) & (US$ Million)
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Gastrointestinal Stromal Tumor Product
Table 65. Novartis Revenue in Gastrointestinal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. ​​Sun Pharmaceutical Company Details
Table 68. ​​Sun Pharmaceutical Business Overview
Table 69. ​​Sun Pharmaceutical Gastrointestinal Stromal Tumor Product
Table 70. ​​Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 71. ​​Sun Pharmaceutical Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Gastrointestinal Stromal Tumor Product
Table 75. Pfizer Revenue in Gastrointestinal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Bayer Aktiengesellschaft Company Details
Table 78. Bayer Aktiengesellschaft Business Overview
Table 79. Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Product
Table 80. Bayer Aktiengesellschaft Revenue in Gastrointestinal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 81. Bayer Aktiengesellschaft Recent Development
Table 82. NATCO Pharma Company Details
Table 83. NATCO Pharma Business Overview
Table 84. NATCO Pharma Gastrointestinal Stromal Tumor Product
Table 85. NATCO Pharma Revenue in Gastrointestinal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 86. NATCO Pharma Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Stromal Tumor Market Share by Type: 2020 VS 2027
Figure 2. Stomach Features
Figure 3. Small Intestine Features
Figure 4. Others Features
Figure 5. Global Gastrointestinal Stromal Tumor Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Specialized Cancer Treatment Centers Case Studies
Figure 9. Other End Users Case Studies
Figure 10. Gastrointestinal Stromal Tumor Report Years Considered
Figure 11. Global Gastrointestinal Stromal Tumor Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Gastrointestinal Stromal Tumor Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Gastrointestinal Stromal Tumor Market Share by Regions: 2020 VS 2027
Figure 14. Global Gastrointestinal Stromal Tumor Market Share by Regions (2022-2027)
Figure 15. Global Gastrointestinal Stromal Tumor Market Share by Players in 2020
Figure 16. Global Top Gastrointestinal Stromal Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Stromal Tumor as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Gastrointestinal Stromal Tumor Revenue in 2020
Figure 18. Global Gastrointestinal Stromal Tumor Revenue Market Share by Type (2016-2021)
Figure 19. Global Gastrointestinal Stromal Tumor Revenue Market Share by Type (2022-2027)
Figure 20. North America Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Gastrointestinal Stromal Tumor Market Share by Type (2016-2027)
Figure 22. North America Gastrointestinal Stromal Tumor Market Share by Application (2016-2027)
Figure 23. North America Gastrointestinal Stromal Tumor Market Share by Country (2016-2027)
Figure 24. United States Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Gastrointestinal Stromal Tumor Market Share by Type (2016-2027)
Figure 28. Europe Gastrointestinal Stromal Tumor Market Share by Application (2016-2027)
Figure 29. Europe Gastrointestinal Stromal Tumor Market Share by Country (2016-2027)
Figure 30. Germany Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Gastrointestinal Stromal Tumor Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Gastrointestinal Stromal Tumor Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Gastrointestinal Stromal Tumor Market Share by Region (2016-2027)
Figure 40. China Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Gastrointestinal Stromal Tumor Market Share by Type (2016-2027)
Figure 48. Latin America Gastrointestinal Stromal Tumor Market Share by Application (2016-2027)
Figure 49. Latin America Gastrointestinal Stromal Tumor Market Share by Country (2016-2027)
Figure 50. Mexico Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Gastrointestinal Stromal Tumor Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Gastrointestinal Stromal Tumor Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Gastrointestinal Stromal Tumor Market Share by Country (2016-2027)
Figure 56. Turkey Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Novartis Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2016-2021)
Figure 60. ​​Sun Pharmaceutical Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2016-2021)
Figure 62. Bayer Aktiengesellschaft Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2016-2021)
Figure 63. NATCO Pharma Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---